, respectively. A liquid chromatographic method with electrochemical detection was used for comparison. The voltammetric method showed good selectivity with respect to both excipients and degradation products. The recovery study exhibited a CV of 0.94% and an average recovery of 98.3%, and it was not necessary to treat the sample before the analysis. The method was successfully applied to the individual tablet assay of lercanidipine in commercial tablets.
D rugs belonging to the 1,4-dihydropyridine group of compounds, such as nifedipine or nitrendipine, reversibly block voltage-dependent Ca +2 influx through L-type channels in cell membranes, generating peripheral vasodilation and reduction in blood pressure. Lercanidipine, 2-[(3,3-diphenylpropyl)methylamine]-1,1-dimethylethylmethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitro phenyl)-3,5-pyridinedicarboxylic ester (Figure 1 ), is a new derivative with potent, long-lasting and vascular-selective calcium entry-blocking activity. The drug is a third-generation dihydropyridine calcium antagonist with a bulky bis-phenylalkylamine side chain, which makes it more lipophilic than related compounds such as amlodipine, nitrendipine, isradipine, and nimodipine. Lercanidipine is used in the treatment of hypertension (1) (2) (3) (4) .
The drug is administered orally in a daily dose of 10-20 mg as the hydrochloride (1, 5) . It is quickly absorbed from the gastrointestinal tract, is widely distributed, and undergoes an extensive first-pass metabolism (1, 6) , generating mainly inactive metabolites. Its half-life of elimination ranges from 2 to 5 h, but the therapeutic action is extended to about 24 h because of its high liposolubility (1, 5) .
Few analytical methods for lercanidipine determination have been described. Among them, a capillary electrophoresis (CE) method to assay both enantiomeric and diasteromeric purity was developed (7) . The enantiomeric separation of dihydropyridine derivatives by means of neutral and negatively charged $-cyclodextrin derivatives by using CE has been described (8) . The results of a clinical pharmacokinetic study of lercanidipine, based on data obtained by liquid chromatography (LC) with UV detection, have also been reported (9) .
As shown in Figure 1 , lercanidipine contains a 1,4-dihydropyridine ring that can undergo electrochemical oxidation, like other compounds belonging to the same class, such as nitrendipine, nimodipine, isradipine, and nisoldipine (10) .
To the best of our knowledge, the electrochemistry of lercanidipine has not been described in the scientific literature. Furthermore, an official method for the determination of this drug in its pharmaceutical forms has not yet been published in any pharmacopeia. Considering this lack of information, we studied the electrochemistry of lercanidipine in order to propose a method that uses differential pulse voltammetry (DPV) and is capable of measuring this drug in commercial tablets. Furthermore, for comparison we determined lercanidipine in tablets by LC with electrochemical detection (11) .
METHOD

Reagents and Drugs
All reagents were analytical grade unless indicated otherwise. 
Voltammetric System
Experiments were performed with a Metrohm 693 VA processor, a 694 VA stand, and a 25 mL thermostat-controlled Metrohm measuring cell, with a glassy carbon electrode as the working electrode, a platinum wire counter electrode and an Ag/AgCl 3M KCl reference electrode. The operating conditions were as follows: sensitivity, 5-10 µA; potential range, 200-1500 mV; ∆Ep, 5 mV; pulse retard, 40 ms; and pulse height, 50 mV. After each recording, the working electrode was cleaned with a chromic acid-sulfuric acid mixture to heavily oxidize the surface and was then thoroughly rinsed according to the recommendations of Adams (12) .
Liquid Chromatography
Measurements were made by using a Waters assembly equipped with a Model 600 controller pump and a Model 996 photodiode array detector. Data were acquired and treated with Millenium Version 2.1 software. A Bondapak/Porasil C 18 chromatographic column, 3.9 × 150 mm, and a C 18 Bondapak guard column, 4.6 × 30 mm, were used. The injector was a 20 µL Rheodyne valve. Electrochemical detection at 1000 mV was used, and the column was kept at constant temperature by a Waters column heater cartridge Model 600.
Isocratic elution with a mobile phase of acetonitrile-0.01M phosphate buffer, pH 4.0 (45 + 55), was used. The flow rate was 1.0 mL/min, and the working temperature was kept constant at 25 ± 1°C. Under these conditions, the retention time of lercanidipine was 5.0 ± 0.7 min (11). 
Preparation of the Calibration Curve
Synthetic Samples
Add excipients (cornstarch, magnesium stearate, lactose, sodium lauryl sulfate, polyethylene glycol 6000, titanium dioxide, carboxymethylcellulose, hydroxypropylmethylcellulose, microcrystalline cellulose, and talc) to the drug for recovery studies, according to the manufacturer's batch formulas for 10.0 mg lercanidipine hydrochloride per tablet. Recovery experiments were performed with 10 synthetic samples, which were analyzed in duplicate. (b) LC.-For this study no fewer than 10 commercial tablets of lercanidipine were used. Suspend each tablet independently in 5 mL ethanol with sonication to ensure complete dissolution of the drug, and dilute to a final volume of 10 mL with mobile phase. Centrifuge each of the solutions for 10 min at 4000 rpm; then take an aliquot of 0.5 mL supernatant, and dilute to 10 mL with mobile phase, obtaining solutions of around 7 × 10 -5 M lercanidipine; measure according to the general procedure described above (11) .
Assay Procedure for Tablets
Selectivity Studies (13) 
Statistical Analysis
The Student's t-test with significance limits between 95 and 99% confidence (15, 16) was used for comparison of the different techniques and the comparison with standard deviations.
Results and Discussion
Lercanidipine in ethanol-0.04M Britton-Robinson buffer (20 + 80) gives an anodic response in a broad pH range, between 2 and 12, when DPV on a glassy carbon electrode is used.
Typical voltammograms of lercanidipine at different pH values are shown in Figure 2 . As can be seen, at strong acidic pH (pH 2.0) a poorly resolved peak near 1000 mV appears. As the pH increased, the resolution improved. This signal can be attributed to the oxidation of the 1,4-dihydropyridine ring to give the corresponding pyridine derivative, as occurs with ÁLVAREZ-LUEJE ET AL.1249 other members of this family (10), according to the well-known overall reaction shown in Figure 3 . Figure 4 shows a plot of peak potential versus pH. Peak potential has a linear relationship to pH, and 4 different zones can be observed, with breaks at pH 4, 7, and 10 and slopes of 10.5, 35.9, 7.2, and 10.0 mV/pH unit for each linear range, respectively. These breaks are presumably due to changes in protonation-deprotonation of the electroactive molecule. On the other hand, peak current is both maximal and stable between pH 3 and 5 and then decreases linearly to become independent of pH at 10 (inset, Figure 4) . By using linear cyclic voltammetry at pH 4, a characteristic irreversible peak was obtained ( Figure 5) . We studied the irreversible peak in a wide range (50-2000 mV/s) of sweep rates. Peak current increases concomitantly as the sweep rate increases. Specifically, we found a linear relationship between the log of peak current and the log of sweep rate with a slope of 0.6444, which indicates that the electrodic process is diffusion controlled (17) .
For analytical purposes, DPV at pH 4.0 was selected. Under these conditions, good values of within-and interday reproducibility were obtained, with coefficient of variation (CV) values of 1.56 and 1.70%, respectively, for 10 successive runs. For quantitation we selected the calibration curve method for lercanidipine concentrations ranging from 1 × 10 -5 to 1 × 10 -4
M at pH 4.0. The analytical parameters are summarized in Table 1 .
To check our proposed method for selectivity, we tried various degradation pathways for lercanidipine. Selectivity is a parameter that describes the capacity of the method to produce a signal that is due only to the presence of the analyte (lercanidipine) with no interference from other components, such as degradation products, metabolites, or pollutants. In our selectivity studies, we evaluated degradation by hydrolysis (acidic, basic, and neutral), photolysis, and chemical oxidation (13).
In both the basic and the acidic hydrolysis of the lercanidipine solution, the voltammetric peak changed dramatically. In 1 h of basic or acid hydrolysis, the drug peak decreased around 90% ( Figure 6 , A and B), and a new signal appeared in the voltammograms, interfering the main signal. In parallel, the degradation was investigated by LC with electrochemical detection, but no new signals were found in the chromatograms after hydrolysis. On the other hand, chemical oxidation of lercanidipine solutions with H 2 O 2 ( Figure 6C ) produced an increase in the peak current and a change in the shape of the polarograms. Similarly, a decrease in the drug peak area with any new signals was observed when the chemical degradation was investigated by LC.
Furthermore, when lercanidipine was exposed to UV radiation at 366 nm for 8 h, the peak current was nearly totally diminished, and a new signal appeared ( Figure 6D ). The same behavior was observed when the photolysis degradation was investigated by LC with electrochemical detection at 1000 mV. On the basis of the above-mentioned selectivity trials, we found the proposed DPV method to be sufficiently selective to be applied to the determination of lercanidipine.
To evaluate the precision and accuracy of the developed method, we performed a recovery study. The results reveal that the precision and accuracy of the voltammetric method are adequate, with an average recovery of 98.3 ± 0.92% and a CV of 0.94%. (The average recovery obtained by LC was 97.59 ± 1.23% with a CV of 2.31%.) Consequently, the voltammetric method can be applied to the determination of lercanidipine in tablets. Also, from these experiments we can conclude that the typical excipients included in the drug formulation (talc, lactose, cornstarch, microcrystalline cellulose, carboxymethylcellulose, and magnesium stearate) do not interfere with the selectivity of the method, and that previous separation or extraction is not necessary.
Finally, the proposed DPV method was applied successfully to individual tablet assay in order to verify content uniformity of the drug product. For comparison, an LC analysis with electrochemical detection at 1000 mV was performed (11) . Table 2 summarizes the results obtained by both methods. The lercanidipine content of all assayed tablets fell within ±15% of the claimed amount, fulfilling the requirement of the United States Pharmacopeia for uniformity content of tablets (18) .
From the statistical analysis of each applied method, we concluded that there were no significant differences between them, and that they were statistically equivalent; we compared the results obtained in the uniformity content test by applying ÁLVAREZ-LUEJE ET AL.1251 the Snedecor F-test (variance proportion) and then the Student's t-test (p < 0.05, n = 10). In addition, we can conclude that the DPV developed method is an adequate tool for the routine determination of lercanidipine in pharmaceutical forms, because the method exhibits an adequate selectivity for the typical excipients tested (talc, lactose, cornstarch, microcrystalline cellulose, carboxymethylcellulose, and magnesium stearate), and acceptable accuracy and reproducibility. Furthermore, treatment of the sample is not required, and the DPV method is not time-consuming and is less expensive than an LC method.
